Naveen Garg

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Jan A. Burger, Michael J. Keating, William G. Wierda et al. · The Lancet Oncology · 2014 · 330 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +8

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Christine M. Parseghian, Jonathan M. Loree, Van K. Morris et al. · Annals of Oncology · 2018 · 228 citations · Full text

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Amanda Cooper, Rebecca Slack, David R. Fogelman et al. · Annals of Surgical Oncology · 2014 · 155 citations · Full text

Surgical Oncology, Pancreatic Cancer, Neoadjuvant Therapy +8

Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison

Abdallah Mohamed, Brian P. Hobbs, Katherine A. Hutcheson et al. · Radiotherapy and Oncology · 2017 · 111 citations · Full text

Adaptive Radiotherapy, Health Sciences, Radiation Therapy +9